2014 SABCS Public Thursday
Read More
San Antonio, TX - SABCS 2014 San Antonio Breast Cancer Symposium - KA Hoadley presents Mutational analysis of CALGB 40601 (Alliance), a neoadjuvant phase III trial of weekly paclitaxel (T) and trastuzumab (H) with or without lapatinib (L) for HER2-positive breast cancer during the General Session here today, Thursday December 11, 2014 during the San Antonio Breast Cancer Symposium being held here at the Henry B. Gonzalez Convention Center in San Antonio, Tex. Over 7500 physicians, researchers, patient advocates and healthcare professionals from over 90 countries attended the meeting which features the latest research on breast cancer treatment and prevention. Photo by © SABCS/Scott Morgan 2014 Technical Questions: todd@medmeetingimages.com
